F Parnis
Clinical Oncology Society of Australia Annual Scientific Meeting 2019
Days
Monday, 11th November
Tuesday, 12th November
Wednesday, 13th November
Thursday, 14th November
Search
Speakers
F Parnis
Abstracts this author is presenting:
Outcomes based on plasma biomarkers for the phase 3 CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (aHCC)
—
Poster Session 1